Greedy Insider · Filing
GRCE · Buy · Opaleye Management Inc.
Opaleye Management Inc. (10% owner) bought 5,027 shares of Grace Therapeutics, Inc. (GRCE) at $1.80, about $9K, on Nov 4, 2026, filed with the SEC on Nov 6, 2026.
Greediness Score 21 · Weak · high confidence. Describes filing structure, not future returns. Not investment advice.
Primary source: SEC EDGAR · Accession 0001493152-26-050313